Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors.
The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.
Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...
Wirral Globe on MSN4d
Wirral cancer survivor takes to London’s Royal Albert Hall stageA WIRRAL woman who was diagnosed with a rare cancerous tumour took centre stage at London’s Royal Albert Hall.
Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.
KLP Kapitalforvaltning AS bought a new position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC.
ShareThe scene Mr OA has always sweated excessively from his palms and arm pits as far back as his memory could go. He’s ...
Verywell Health on MSN1d
Ask an Expert: How Can Breast Cancer Patients Make the Best Treatment Choices?Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.
Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback